UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma

Cancers, 2020-08, Vol.12 (8), p.2182

2020

Volltextzugriff (PDF)

Photoacoustic detection of metastatic melanoma cells in the human circulatory system

Optics letters, 2006-10, Vol.31 (20), p.2998

2006

Volltextzugriff (PDF)

1244 Polarized immune responses reveal actionable therapeutic targets in cutaneous adverse events to checkpoint inhibitors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1374-A1374

2023

Volltextzugriff (PDF)

Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?

Reviews on recent clinical trials, 2016-06, Vol.11 (2), p.81-86

2016

Volltextzugriff (PDF)

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells

EBioMedicine, 2015-11, Vol.2 (11), p.1821-1826

2015

Volltextzugriff (PDF)

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

Journal of the National Comprehensive Cancer Network, 2020-03, Vol.18 (3), p.230-241

2020

Volltextzugriff (PDF)

43858 The 31-gene expression profile test for cutaneous melanoma identifies patients with stage IB- IIA disease who have recurrence risk similar to that of stage IIB-IIC disease

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB230-AB230

2023

Volltextzugriff (PDF)

Checkpoint inhibitor-related skin reactions in cancer patients are characterized by unique rash specific immune responses

Journal of allergy and clinical immunology, 2024-02, Vol.153 (2), p.AB227

2024

Volltextzugriff (PDF)

CemiplimAb-rwlc survivorship and epidemiology (CASE): A prospective study of safety and efficacy of cemiplimab in patients with advanced basal cell carcinoma in a real-world setting

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS9614-TPS9614

2023

Volltextzugriff (PDF)

A phase 3 trial comparing fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) to pembrolizumab in patients with completely resected high-risk melanoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS9598-TPS9598

2023

Volltextzugriff (PDF)

Detection of circulating tumor cells by photoacoustic flowmetry

Methods in molecular biology (Clifton, N.J.), 2014, Vol.1102, p.655

2014

Volltextzugriff (PDF)

Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways

Clinical cancer research, 2024-07, Vol.30 (13), p.2822-2834

2024

Volltextzugriff (PDF)

Adjuvant nivolumab in high-risk stage IIb/IIc melanoma patients: Results from investigator initiated clinical trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9583-9583

2021

Volltextzugriff (PDF)

Circulating cell free DNA to predict recurrence in uveal melanoma

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9569-9569

2016

Volltextzugriff (PDF)

Effect of pretreatment steroids on the development of immune related adverse events

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15095-e15095

2018

Volltextzugriff (PDF)

Impact of age on immune checkpoint blockade tolerability across malignancies: A single institution review

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15069-e15069

2018

Volltextzugriff (PDF)

Impact of comorbidity on immune checkpoint blockade tolerance across tumor types

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15068-e15068

2018

Volltextzugriff (PDF)

Abstract 471: Detection of circulating tumor cells in high-risk primary uveal melanoma by the photoacoustic method

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.471-471

2016

Volltextzugriff (PDF)

Thyroid-related laboratory abnormalities to predict treatment-limiting adverse events in melanoma patients treated with immune checkpoint blockade

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14536-e14536

2016

Volltextzugriff (PDF)

Abstract CT144: Intratumoral toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab can reverse resistance to PD-1 inhibition in a phase Ib trial in subjects with advanced melanoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.CT144-CT144

2018

Volltextzugriff (PDF)

Liver-directed treatment for patients with uveal melanoma hepatic metastasis: A retrospective analysis of overall survival

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.9592-9592

2018

Volltextzugriff (PDF)

Resolution of pre-cancerous and non-melanoma skin cancers after immune checkpoint inhibitor treatments

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14540-e14540

2016

Volltextzugriff (PDF)

Abstract 384: Detection of circulating melanoma cells in paired arterial and venous specimens from uveal melanoma patients with hepatic metastatic

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.384-384

2015

Volltextzugriff (PDF)

Estimating and benchmarking Less-than-Truckload market rates

Transportation research. Part E, Logistics and transportation review, 2010-09, Vol.46 (5), p.667-682

2010

Volltextzugriff (PDF)

Detection of circulating melanoma cells in human blood using photoacoustic flowmetry

2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2009-01, Vol.2009, p.106-109

2009

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

ThemaCancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(16)
Humans
(12)
Male
(6)
Urology & Nephrology
(6)
Adult
(5)
Oncology
(5)
Aged
(4)
Female
(4)
Middle Aged
(4)
Retrospective Studies
(4)
Engineering
(3)
Melanoma
(3)
Neoplastic Cells, Circulating - Pathology
(3)
Treatment Outcome
(3)
Aged, 80 And Over
(2)
Cancer Detection
(2)
Cell Line, Tumor
(2)
Clinical Trials
(2)
General & Internal Medicine
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma

Photoacoustic detection of metastatic melanoma cells in the human circulatory system

1244 Polarized immune responses reveal actionable therapeutic targets in cutaneous adverse events to checkpoint inhibitors

Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

43858 The 31-gene expression profile test for cutaneous melanoma identifies patients with stage IB- IIA disease who have recurrence risk similar to that of stage IIB-IIC disease

Checkpoint inhibitor-related skin reactions in cancer patients are characterized by unique rash specific immune responses

CemiplimAb-rwlc survivorship and epidemiology (CASE): A prospective study of safety and efficacy of cemiplimab in patients with advanced basal cell carcinoma in a real-world setting

A phase 3 trial comparing fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) to pembrolizumab in patients with completely resected high-risk melanoma

Detection of circulating tumor cells by photoacoustic flowmetry

Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways

Adjuvant nivolumab in high-risk stage IIb/IIc melanoma patients: Results from investigator initiated clinical trial

Circulating cell free DNA to predict recurrence in uveal melanoma

Effect of pretreatment steroids on the development of immune related adverse events

Impact of age on immune checkpoint blockade tolerability across malignancies: A single institution review

Impact of comorbidity on immune checkpoint blockade tolerance across tumor types

Abstract 471: Detection of circulating tumor cells in high-risk primary uveal melanoma by the photoacoustic method

Thyroid-related laboratory abnormalities to predict treatment-limiting adverse events in melanoma patients treated with immune checkpoint blockade

Abstract CT144: Intratumoral toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab can reverse resistance to PD-1 inhibition in a phase Ib trial in subjects with advanced melanoma

Liver-directed treatment for patients with uveal melanoma hepatic metastasis: A retrospective analysis of overall survival

Resolution of pre-cancerous and non-melanoma skin cancers after immune checkpoint inhibitor treatments

Abstract 384: Detection of circulating melanoma cells in paired arterial and venous specimens from uveal melanoma patients with hepatic metastatic

Estimating and benchmarking Less-than-Truckload market rates

Detection of circulating melanoma cells in human blood using photoacoustic flowmetry

Aktive Filter

Suchergebnisse filtern